ArticleCureus2026
Autism Spectrum Disorder Associated With a CACNA1I Variant of Uncertain Significance: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental condition with multifactorial etiologies, and accumulating evidence suggests that ion channel dysfunction may contribute to a subset of phenotypes. We report a six-year-old Saudi girl with early-onset and persistent deficits in social communication, profound speech impairment, stereotyped behaviors, sensory dysregulation, and significant adaptive and cognitive delays. Standardized assessments demonstrated moderate global delay (Vineland composite score 42), clinically significant social communication impairment (SRS-2 total T-score 64, with earlier documentation exceeding 90), and moderate nonverbal cognitive delay (Leiter-3 nonverbal IQ 43). Whole-exome sequencing (CentoGenome® MOX 1.0 Solo) identified a heterozygous CACNA1I missense variant (NM_021096.3:c.6028G>T; p.Ala2010Ser) classified as a variant of uncertain significance, not present in population databases and interpreted as potentially de novo, with a possible splice effect flagged despite largely benign in silico predictions. The child received multidisciplinary interventions, including ABA-based behavioral therapy, speech therapy, occupational therapy, and risperidone for behavioral dysregulation, with mild improvement in social responsiveness but persistent minimal language and limited adaptive functioning. This case adds to emerging reports linking CACNA1I variation to neurodevelopmental phenotypes characterized by prominent speech impairment and highlights the clinical challenge of counseling families when a potentially relevant de novo finding remains classified as a variant of uncertain significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.